{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:52:24Z","timestamp":1781513544649,"version":"3.54.1"},"reference-count":64,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Colorectal cancer [CRC] is among the most fatal types of cancer. An\nactive targeting delivery system that specifically interacts with CRC cells could improve the\ntherapy's outcomes. Herein, Cetuximab single-chain fragment variable antibody [scFv] fragments\nwere conjugated to the surface of 5-FU encapsulated chitosan nanoparticles [CS NPs] to\ndevelop an effective therapeutic platform [scFv-CS\/5-FU NPs].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>CS\/5-FU NPs were synthesized using a special fluidic system. Encapsulation efficiency\n[EE], loading capacity [LC], and the drug release profile of the particles were determined. scFv\nfragments were produced recombinantly and tailored on the surface of CS\/5-FU NPs. The physicochemical\nfeatures of scFv-CS\/5-FU NPs were also characterized. MTT and flow cytometry\nassay investigated the toxicity effect of scFv-CS\/5-FU NPs on the HCT116 cell line.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>CS\/5-FU NPs had a homogenous spherical shape. They possessed sustainable drugrelease\nbehavior. The produced scFv-CS\/5-FU NPs were also spherical. scFv-CS\/5-FU NPs significantly\ndecreased the viability of cancerous cells in a dose-dependent manner and induced\napoptosis in 97.97% of targeted cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>scFv-CS\/5-FU NPs showed remarkable anti-CRC activity. This novel targeting\ndelivery system reduced the effective dose of 5-FU which is of vital importance to decrease the\ndevastating side effects of chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010340791241025033549","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T06:31:14Z","timestamp":1730442674000},"page":"578-592","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cetuximab scFv-modified 5-FU Loaded Chitosan Nanoparticles: A Novel Therapeutic Platform"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5473-147X","authenticated-orcid":true,"given":"Masumeh","family":"Jalalvand","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2936-5890","authenticated-orcid":true,"given":"Fariba","family":"Esmaeili","sequence":"additional","affiliation":[{"name":"Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-5485","authenticated-orcid":true,"given":"Khadijeh","family":"Falahzadeh","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5370-3111","authenticated-orcid":true,"given":"Mohammadali","family":"Mazloumi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-5192","authenticated-orcid":true,"given":"Gholamreza","family":"Shahsavari","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0502-7870","authenticated-orcid":true,"given":"Elham","family":"Bayat","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2329-3884","authenticated-orcid":true,"given":"Farshid","family":"Zandsalimi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences,Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1988-4419","authenticated-orcid":true,"given":"Yeganeh","family":"Talebkhan","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-8764","authenticated-orcid":true,"given":"Leila","family":"Nematollahi","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8742-9138","authenticated-orcid":true,"given":"Babak","family":"Negahdari","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1002\/cam4.5596","volume":"12","author":"Okimoto K.","unstructured":"Okimoto K.; Hirotsu Y.; Arai M.; Amemiya K.; Akizue N.; Ohta Y.; Taida T.; Saito K.; Ohyama H.; Matsumura T.; Validity of pathological diagnosis for early colorectal cancer in genetic background. Cancer Med  ,12(7),8490-8498","journal-title":"Cancer Med"},{"key":"ref=2","year":"2022","unstructured":"Colorectal cancer awareness month 2022.  Available from:  https:\/\/www.iarc.who.int\/featured-news\/colorectal-cancer-awareness-month-2022\/2022"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cgh.2018.07.030","volume":"17","author":"Murphy N.","year":"2019","unstructured":"Murphy N.; Ward H.A.; Jenab M.; Rothwell J.A.; Boutron-Ruault M.-C.; Carbonnel F.; Kvaskoff M.; Kaaks R.; K\u00fchn T.; Boeing H.; Heterogeneity of colorectal cancer risk factors by anatomical subsite in 10 European countries: A multinational cohort study. J Gastroenterol Hepatol  2019,17(7),1323-1331","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2011-300537","volume":"62","author":"Dunlop M.G.","year":"2013","unstructured":"Dunlop M.G.; Tenesa A.; Farrington S.M.; Ballereau S.; Brewster D.H.; Koessler T.; Pharoah P.; Schafmayer C.; Hampe J.; V\u00f6lzke H.; Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals. Gut  2013,62(6),871-881","journal-title":"Gut"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1136\/gutjnl-2015-309647","volume":"65","author":"Carballal S.","year":"2016","unstructured":"Carballal S.; Rodr\u00edguez-Alcalde D.; Moreira L.; Hern\u00e1ndez L.; Rodr\u00edguez L.; Rodr\u00edguez-Moranta F.; Gonzalo V.; Bujanda L.; Bessa X.; Poves C.; Cubiella J.; Castro I.; Gonz\u00e1lez M.; Moya E.; Oqui\u00f1ena S.; Clofent J.; Quintero E.; Esteban P.; Pi\u00f1ol V.; Fern\u00e1ndez F.J.; Jover R.; Cid L.; L\u00f3pez-Cer\u00f3n M.; Cuatrecasas M.; L\u00f3pez-Vicente J.; Leoz M.L.; Rivero-S\u00e1nchez L.; Castells A.; Pellis\u00e9 M.; Balaguer F.; Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study. Gut  2016,65(11),1829-1837","journal-title":"Gut"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/000313481508100329","volume":"81","author":"Maglio R.","year":"2015","unstructured":"Maglio R.; Muzi G.M.; Massimo M.M.; Masoni L.; Transanal minimally invasive surgery (TAMIS): New treatment for early rectal cancer and large rectal polyps\u2014experience of an Italian center. Am Surg  2015,81(3),273-277","journal-title":"Am Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3748\/wjg.v20.i4.877","volume":"20","author":"Damin D.C.","year":"2014","unstructured":"Damin D.C.; Lazzaron A.R.; Evolving treatment strategies for colorectal cancer: A critical review of current therapeutic options. World J Gastroenterol  2014,20(4),877-887","journal-title":"World J Gastroenterol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ctrv.2017.04.007","volume":"59","author":"Vogel A.","year":"2017","unstructured":"Vogel A.; Hofheinz R.D.; Kubicka S.; Arnold D.; Treatment decisions in metastatic colorectal cancer \u2013 Beyond first and second line combination therapies. Cancer Treat Rev  2017,59,54-60","journal-title":"Cancer Treat Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"Vodenkova S.","year":"2020","unstructured":"Vodenkova S.; Buchler T.; Cervena K.; Veskrnova V.; Vodicka P.; Vymetalkova V.; 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther  2020,206,107447","journal-title":"Pharmacol Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/MLR.0000000000000510","volume":"54","author":"Bradley C.J.","year":"2016","unstructured":"Bradley C.J.; Yabroff K.R.; Warren J.L.; Zeruto C.; Chawla N.; Lamont E.B.; Trends in the treatment of metastatic colon and rectal cancer in elderly patients. Med Care  2016,54(5),490-497","journal-title":"Med Care"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"Hossain M.S.","year":"2022","unstructured":"Hossain M.S.; Karuniawati H.; Jairoun A.A.; Urbi Z.; Ooi D.J.; John A.; Lim Y.C.; Kibria K.M.K.; Mohiuddin A.K.M.; Ming L.C.; Goh K.W.; Hadi M.A.; Colorectal cancer: A review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers (Basel)  2022,14(7),1732","journal-title":"Cancers (Basel)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7014","DOI":"10.3748\/wjg.v21.i22.7014","volume":"21","author":"Ihn\u00e1t P.","year":"2015","unstructured":"Ihn\u00e1t P.; V\u00e1vra P.; Zon\u010da P.; Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go? World J Gastroenterol  2015,21(22),7014-7021","journal-title":"World J Gastroenterol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/ijms23031685","volume":"23","author":"Mundekkad D.","year":"2022","unstructured":"Mundekkad D.; Cho W.C.; Nanoparticles in clinical translation for cancer therapy. Int J Mol Sci  2022,23(3),1685","journal-title":"Int J Mol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"101533","DOI":"10.1016\/j.jddst.2020.101533","volume":"56","author":"Aghamiri S.","year":"2020","unstructured":"Aghamiri S.; Talaei S.; Ghavidel A.A.; Zandsalimi F.; Masoumi S.; Hafshejani N.H.; Jajarmi V.; Nanoparticles-mediated CRISPR\/Cas9 delivery: Recent advances in cancer treatment. J Drug Deliv Sci Technol  2020,56,101533","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"213279","DOI":"10.1016\/j.bioadv.2023.213279","volume":"146","author":"Mata R.","year":"2023","unstructured":"Mata R.; Nakkala J.R.; Sadras S.R.; Therapeutic role of biogenic silver and gold nanoparticles against a DMH-induced colon cancer model. Biomater Adv  2023,146,213279","journal-title":"Biomater Adv"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"100501","DOI":"10.1016\/j.mcpro.2023.100501","volume":"22","author":"Maduni\u0107 K.","year":"2023","unstructured":"Maduni\u0107 K.; Luijkx Y.M.C.A.; Mayboroda O.A.; Janssen G.M.C.; van Veelen P.A.; Strijbis K.; Wennekes T.; Lageveen-Kammeijer G.S.M.; Wuhrer M.; O-glycomic and proteomic signatures of spontaneous and butyrate-stimulated colorectal cancer cell line differentiation. Mol Cell Proteomics  2023,22(3),100501","journal-title":"Mol Cell Proteomics"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2217\/nnm-2022-0214","volume":"17","author":"Abdelgalil R.M.","year":"2022","unstructured":"Abdelgalil R.M.; Elmorshedy Y.M.; Elkhodairy K.A.; Teleb M.; Bekhit A.A.; Khattab S.N.; Elzoghby A.O.; Engineered Nanomedicines for Augmenting the Efficacy of Colorectal Cancer Immunotherapy. Nanomed J  2022,17(22),1721-1745","journal-title":"Nanomed J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/1061186X.2016.1184272","volume":"25","author":"Li X.","year":"2017","unstructured":"Li X.; Tsibouklis J.; Weng T.; Zhang B.; Yin G.; Feng G.; Cui Y.; Savina I.N.; Mikhalovska L.I.; Sandeman S.R.; Howel C.A.; Mikhalovsky S.V.; Nano carriers for drug transport across the blood\u2013brain barrier. J Drug Target  2017,25(1),17-28","journal-title":"J Drug Target"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/IJN.S146315","volume":"12","year":"2017","unstructured":"ud Din, F.; Aman, W.; Ullah, I.; Qureshi, O.S.; Mustapha, O.; Shafique, S.; Zeb, A. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine  2017,12,7291-7309","journal-title":"Int J Nanomedicine"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.7150\/thno.38069","volume":"10","author":"Mi P.","year":"2020","unstructured":"Mi P.; Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics. Theranostics  2020,10(10),4557-4588","journal-title":"Theranostics"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"101532","DOI":"10.1016\/j.nantod.2022.101532","volume":"45","author":"Ashrafizadeh M.","year":"2022","unstructured":"Ashrafizadeh M.; Aghamiri S.; Tan S.C.; Zarrabi A.; Sharifi E.; Rabiee N.; Kadumudi F.B.; Pirouz A.D.; Delfi M.; Byrappa K.; Thakur V.K.; Sharath Kumar K.S.; Girish Y.R.; Zandsalimi F.; Zare E.N.; Orive G.; Tay F.; Hushmandi K.; Kumar A.P.; Karaman C.; Karimi-Maleh H.; Mostafavi E.; Makvandi P.; Wang Y.; Nanotechnological approaches in prostate cancer therapy: Integration of engineering and biology. Nano Today  2022,45,101532","journal-title":"Nano Today"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"650598","DOI":"10.3389\/fbioe.2021.650598","volume":"9","author":"Feng P.","year":"2021","unstructured":"Feng P.; Luo Y.; Ke C.; Qiu H.; Wang W.; Zhu Y.; Hou R.; Xu L.; Wu S.; Chitosan-based functional materials for skin wound repair: Mechanisms and applications. Front Bioeng Biotechnol  2021,9,650598","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fbioe.2020.00389","volume":"8","author":"Ojeda-Hern\u00e1ndez D.D.","year":"2020","unstructured":"Ojeda-Hern\u00e1ndez D.D.; Canales-Aguirre A.A.; Matias-Guiu J.; Gomez-Pinedo U.; Mateos-D\u00edaz J.C.; Potential of chitosan and its derivatives for biomedical applications in the central nervous system. Front Bioeng Biotechnol  2020,8,389","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"103598","DOI":"10.1016\/j.elstat.2021.103598","volume":"112","author":"Esmaeili F.","year":"2021","unstructured":"Esmaeili F.; Aghajani M.; Rashti A.; Abdollahi M.; Faridi-Majidi R.; Ghanbari H.; Amani A.; Parameters influencing size of electrosprayed chitosan\/HPMC\/TPP nanoparticles containing alendronate by an artificial neural networks model. J Electrost  2021,112,103598","journal-title":"J Electrost"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.colsurfb.2018.11.018","volume":"174","author":"Sahu P.","year":"2019","unstructured":"Sahu P.; Kashaw S.K.; Sau S.; Kushwah V.; Jain S.; Agrawal R.K.; Iyer A.K.; pH responsive 5-fluorouracil loaded biocompatible nanogels for topical chemotherapy of aggressive melanoma. Colloids Surf B Biointerfaces  2019,174,232-245","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2217\/nnm-2016-0194","volume":"11","author":"Cisterna B.A.","year":"2016","unstructured":"Cisterna B.A.; Kamaly N.; Choi W.I.; Tavakkoli A.; Farokhzad O.C.; Vilos C.; Targeted nanoparticles for colorectal cancer. Nanomedicine (Lond)  2016,11(18),2443-2456","journal-title":"Nanomedicine (Lond)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/pharmaceutics14061213","volume":"14","author":"Krasteva N.","year":"2022","unstructured":"Krasteva N.; Georgieva M.; Promising therapeutic strategies for colorectal cancer treatment based on nanomaterials. Pharmaceutics  2022,14(6),1213","journal-title":"Pharmaceutics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","volume":"320","author":"Marques A.C.","year":"2020","unstructured":"Marques A.C.; Costa P.J.; Velho S.; Amaral M.H.; Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. J Control Release  2020,320,180-200","journal-title":"J Control Release"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1039\/c1pp05014a","volume":"10","author":"Stuchinskaya T.","year":"2011","unstructured":"Stuchinskaya T.; Moreno M.; Cook M.J.; Edwards D.R.; Russell D.A.; Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem Photobiol Sci  2011,10(5),822-831","journal-title":"Photochem Photobiol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1476-5381.2009.00190.x","volume":"157","author":"Chames P.","year":"2009","unstructured":"Chames P.; Van Regenmortel M.; Weiss E.; Baty D.; Therapeutic antibodies: Successes, limitations and hopes for the future. Br J Pharmacol  2009,157(2),220-233","journal-title":"Br J Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"106639","DOI":"10.1016\/j.intimp.2020.106639","volume":"85","author":"Parray H.A.","year":"2020","unstructured":"Parray H.A.; Shukla S.; Samal S.; Shrivastava T.; Ahmed S.; Sharma C.; Kumar R.; Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives. Int Immunopharmacol  2020,85,106639","journal-title":"Int Immunopharmacol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1021\/acsomega.8b00591","volume":"3","author":"Tripathi K.","year":"2018","unstructured":"Tripathi K.; Driskell J.D.; Quantifying bound and active antibodies conjugated to gold nanoparticles: A comprehensive and robust approach to evaluate immobilization chemistry. ACS Omega  2018,3(7),8253-8259","journal-title":"ACS Omega"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2174\/0929867324666170817152554","volume":"26","author":"Kholodenko R.V.","year":"2019","unstructured":"Kholodenko R.V.; Kalinovsky D.V.; Doronin I.I.; Ponomarev E.D.; Kholodenko I.V.; Antibody fragments as potential biopharmaceuticals for cancer therapy: Success and limitations. Curr Med Chem  2019,26(3),396-426","journal-title":"Curr Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.4161\/cbt.8.11.8531","volume":"8","author":"Zhu H.","year":"2009","unstructured":"Zhu H.; Yang B.; Yang X.; Wang L.; Xu J.; Liao C.; Feng Q.; Tang H.; Hu L.; Chen Z.; Li Y.; A novel antibody fragment targeting HAb18G\/CD147 with cytotoxicity and decreased immunogenicity. Cancer Biol Ther  2009,8(11),1035-1044","journal-title":"Cancer Biol Ther"},{"key":"ref=35","author":"Jalalvand M.","year":"2023","unstructured":"Jalalvand M.; Falahzadeh K.; Jalalvand A.; Mazloumi M.; Shahsavari G.; Optimization of the expression of recombinant cetuximab single-chain fragment variable and comparative its purification with magnetic nanoparticles and conventional fast protein liquid chromatography. Biointerface Res Appl Chem  2023","journal-title":"Biointerface Res Appl Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"17904","DOI":"10.1038\/srep17904","volume":"5","author":"Zhu R.","year":"2015","unstructured":"Zhu R.; Zhang C.; Liu Y.; Yuan Z.; Chen W.; Yang S.; Li J.; Zhu W.; Zhou X.; You B.; Zhang X.; CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with \u03b1-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells. Sci Rep  2015,5(1),17904","journal-title":"Sci Rep"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/pharmaceutics14050927","volume":"14","author":"Saravanakumar K.","year":"2022","unstructured":"Saravanakumar K.; Sathiyaseelan A.; Park S.; Kim S.R.; Priya V.V.; Wang M.H.; Monoclonal antibody functionalized, and L-lysine \u03b1-oxidase loaded PEGylated-chitosan nanoparticle for HER2\/Neu targeted breast cancer therapy. Pharmaceutics  2022,14(5),927","journal-title":"Pharmaceutics"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"6940","DOI":"10.1021\/la049524t","volume":"20","author":"Ito T.","year":"2004","unstructured":"Ito T.; Sun L.; Bevan M.A.; Crooks R.M.; Comparison of nanoparticle size and electrophoretic mobility measurements using a carbon-nanotube-based coulter counter, dynamic light scattering, transmission electron microscopy, and phase analysis light scattering. Langmuir  2004,20(16),6940-6945","journal-title":"Langmuir"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jddst.2015.04.007","volume":"30","author":"Miladi K.","year":"2015","unstructured":"Miladi K.; Sfar S.; Fessi H.; Elaissari A.; Enhancement of alendronate encapsulation in chitosan nanoparticles. J Drug Deliv Sci Technol  2015,30,391-396","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=40","first-page":"42","volume":"2012","author":"Aydin R.S.T.","year":"2012","unstructured":"Aydin R.S.T.; Pulat M.; 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: Evaluation of controlled release kinetics. J Nanomater  2012,2012,42","journal-title":"J Nanomater"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"109885","DOI":"10.1016\/j.msec.2019.109885","volume":"104","author":"de Carvalho F.G.","year":"2019","unstructured":"de Carvalho F.G.; Magalh\u00e3es T.C.; Teixeira N.M.; Gondim B.L.C.; Carlo H.L.; dos Santos R.L.; de Oliveira A.R.; Denadai \u00c2.M.L.; Synthesis and characterization of TPP\/chitosan nanoparticles: Colloidal mechanism of reaction and antifungal effect on C. albicans biofilm formation. Mater Sci Eng C  2019,104,109885","journal-title":"Mater Sci Eng C"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"9273","DOI":"10.3390\/molecules19079273","volume":"19","author":"Pineda M.","year":"2014","unstructured":"Pineda M.; Torres S.; L\u00f3pez L.; Enr\u00edquez-Medrano F.; De Le\u00f3n R.; Fern\u00e1ndez S.; Saade H.; L\u00f3pez R.; Chitosan-coated magnetic nanoparticles prepared in one-step by precipitation in a high-aqueous phase content reverse microemulsion. Molecules  2014,19(7),9273-9287","journal-title":"Molecules"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/annonc\/mdu253","volume":"26","author":"Papamichael D.","year":"2015","unstructured":"Papamichael D.; Audisio R.A.; Glimelius B.; de Gramont A.; Glynne-Jones R.; Haller D.; K\u00f6hne C.H.; Rostoft S.; Lemmens V.; Mitry E.; Rutten H.; Sargent D.; Sastre J.; Seymour M.; Starling N.; Van Cutsem E.; Aapro M.; Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol  2015,26(3),463-476","journal-title":"Ann Oncol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00384-018-3202-8","volume":"34","author":"Wrobel P.","year":"2019","unstructured":"Wrobel P.; Ahmed S.; Current status of immunotherapy in metastatic colorectal cancer. Int J Colorectal Dis  2019,34(1),13-25","journal-title":"Int J Colorectal Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/polym12061397","volume":"12","author":"Das S.S.","year":"2020","unstructured":"Das S.S.; Bharadwaj P.; Bilal M.; Barani M.; Rahdar A.; Taboada P.; Bungau S.; Kyzas G.Z.; Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers (Basel)  2020,12(6),1397","journal-title":"Polymers (Basel)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/molecules26061770","volume":"26","author":"Amiri M.S.","year":"2021","unstructured":"Amiri M.S.; Mohammadzadeh V.; Yazdi M.E.T.; Barani M.; Rahdar A.; Kyzas G.Z.; Plant-based gums and mucilages applications in pharmacology and nanomedicine: A review. Molecules  2021,26(6),1770","journal-title":"Molecules"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4","volume":"63","author":"Calvo P.","year":"1997","unstructured":"Calvo P.; Remunan-Lopez C.; Vila-Jato J.L.; Alonso M.; Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci  1997,63(1),125-132","journal-title":"J Appl Polym Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1021\/mp300162j","volume":"9","author":"Koukaras E.N.","year":"2012","unstructured":"Koukaras E.N.; Papadimitriou S.A.; Bikiaris D.N.; Froudakis G.E.; Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate. Mol Pharm  2012,9(10),2856-2862","journal-title":"Mol Pharm"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/polym14040662","volume":"14","author":"Hoang N.H.","year":"2022","unstructured":"Hoang N.H.; Le Thanh T.; Sangpueak R.; Treekoon J.; Saengchan C.; Thepbandit W.; Papathoti N.K.; Kamkaew A.; Buensanteai N.; Chitosan nanoparticles-based ionic gelation method: A promising candidate for plant disease management. Polymers (Basel)  2022,14(4),662","journal-title":"Polymers (Basel)"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/pi.5970","volume":"69","author":"Pedroso-Santana S.","year":"2020","unstructured":"Pedroso-Santana S.; Fleitas-Salazar N.; Ionotropic gelation method in the synthesis of nanoparticles\/microparticles for biomedical purposes. Polym Int  2020,69(5),443-447","journal-title":"Polym Int"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1248\/cpb.59.272","volume":"59","author":"Nagarwal R.C.","year":"2011","unstructured":"Nagarwal R.C.; Nath Singh P.; Kant S.; Maiti P.; Pandit J.K.; Chitosan nanoparticles of 5-fluorouracil for ophthalmic delivery: Characterization, in-vitro and in-vivo study. Chem Pharm Bull (Tokyo)  2011,59(2),272-278","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-816505-8.00013-8","author":"Barba A.A.","year":"2019","unstructured":"Barba A.A.; Bochicchio S.; Dalmoro A.; Caccavo D.; Cascone S.; Lamberti G.; Chapter 10 - Polymeric and lipid-based systems for controlled drug release: an engineering point of view. Nanomaterials for Drug Delivery and Therapy  2019,267-304","journal-title":"Nanomaterials for Drug Delivery and Therapy"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"932932","DOI":"10.4061\/2011\/932932","volume":"2011","author":"Krasinskas A.M.","year":"2011","unstructured":"Krasinskas A.M.; EGFR signaling in colorectal carcinoma. Patholog Res Int  2011,2011,932932","journal-title":"Patholog Res Int"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","volume":"5","author":"Xie Y.H.","year":"2020","unstructured":"Xie Y.H.; Chen Y.X.; Fang J.Y.; Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther  2020,5(1),22","journal-title":"Signal Transduct Target Ther"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3390\/vaccines10040499","volume":"10","author":"Janani B.","year":"2022","unstructured":"Janani B.; Vijayakumar M.; Priya K.; Kim J.H.; Prabakaran D.S.; Shahid M.; Al-Ghamdi S.; Alsaidan M.; Othman Bahakim N.; Hassan Abdelzaher M.; Ramesh T.; EGFR-based targeted therapy for colorectal cancer - Promises and challenges. Vaccines (Basel)  2022,10(4),499","journal-title":"Vaccines (Basel)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2015.05.271","volume":"210","author":"Zalba S.","year":"2015","unstructured":"Zalba S.; Contreras A.M.; Haeri A.; ten Hagen T.L.M.; Navarro I.; Koning G.; Garrido M.J.; Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer. J Control Release  2015,210,26-38","journal-title":"J Control Release"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/biot.200500051","volume":"1","author":"Graumann K.","year":"2006","unstructured":"Graumann K.; Premstaller A.; Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnol J  2006,1(2),164-186","journal-title":"Biotechnol J"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4172\/2157-7013.1000221","volume":"6","author":"Joseph B.C.","year":"2015","unstructured":"Joseph B.C.; Pichaimuthu S.; Srimeenakshi S.; Murthy M.; Selvakumar K.; Ganesan M.; An overview of the parameters for recombinant protein expression in Escherichia coli. J Cell Sci Ther  2015,6(5),221","journal-title":"J Cell Sci Ther"},{"key":"ref=59","first-page":"21","volume":"5","author":"Saletti P.","year":"2015","unstructured":"Saletti P.; Molinari F.; De Dosso S.; Frattini M.; EGFR signaling in colorectal cancer: A clinical perspective. Gastrointest Cancer  2015,5,21-38","journal-title":"Gastrointest Cancer"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ajps.2017.04.002","volume":"12","author":"Sun L.","year":"2017","unstructured":"Sun L.; Chen Y.; Zhou Y.; Guo D.; Fan Y.; Guo F.; Zheng Y.; Chen W.; Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo. Asian J Pharm Sci  2017,12(5),418-423","journal-title":"Asian J Pharm Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3390\/nano11071691","volume":"11","author":"Yusefi M.","year":"2021","unstructured":"Yusefi M.; Chan H.Y.; Teow S.Y.; Kia P.; Lee-Kiun Soon M.; Sidik N.A.B.C.; Shameli K.; 5-fluorouracil encapsulated chitosan-cellulose fiber bionanocomposites: Synthesis, characterization and in vitro analysis towards colorectal cancer cells. Nanomaterials (Basel)  2021,11(7),1691","journal-title":"Nanomaterials (Basel)"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/aps.2017.45","volume":"38","author":"Cui Y.","year":"2017","unstructured":"Cui Y.; Xu Q.; Davoodi P.; Wang D.; Wang C.H.; Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Acta Pharmacol Sin  2017,38(6),943-953","journal-title":"Acta Pharmacol Sin"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1423-0127-20-16","volume":"20","author":"Chan D.V.","year":"2013","unstructured":"Chan D.V.; Sharma R.; Ju C.Y.A.; Roffler S.R.; Ju S.T.; A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer. J Biomed Sci  2013,20(1),16","journal-title":"J Biomed Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12951-023-02126-4","volume":"21","author":"Silveira M.J.","year":"2023","unstructured":"Silveira M.J.; Martins C.; Cruz T.; Castro F.; Amorim-Costa \u00c2.; Chester K.; Oliveira M.J.; Sarmento B.; scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells. J Nanobiotechnology  2023,21(1),357","journal-title":"J Nanobiotechnology"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010340791241025033549","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/235966\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010340791241025033549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:56:23Z","timestamp":1781510183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/235966\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010340791241025033549","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}